Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr
Business Of Biotech
00:00
Introduction
The founder and CEO of Context Therapeutics discusses the company's work in hormone-driven breast and gynecological cancers, focusing on creating efficiencies in therapy development. He also shares his experience transitioning from a molecular biologist to the venture capital world.
Transcript
Play full episode
